肝内乙肝病毒cccDNA的研究进展
摘要
肝内HBVcccDNA被认为在乙肝病毒持续感染中是停药反跳和病毒耐药的关键因素.本文就肝内HBVcccDNA的产生、属性、检测方法、清除机制,及与现有抗病毒治疗的关系,作了综述.期望为终结乙肝病毒持续感染提供一些理论基础.
出处
《国际病毒学杂志》
2008年第6期-,共5页
International Journal of Virology
参考文献21
-
1Lee WM. Hepatitis B virus infection[J].New England Journal of Medicine,1997.1733-1745.doi:10.1056/NEJM199712113372406.
-
2Ganem D,Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J].New England Journal of Medicine,2004.1118-1129.doi:10.1056/NEJMra031087.
-
3Seeger C;Mason WS.Hepatitis B virus biology[J]Microbiology and Molecular Biology Reviews,2000(01):51-68.
-
4Tuttleman j,Pourcel C,SummersJ. Formation of the pool of covalently closed circular viral DNA in hepadnavirus infected cells[J].Cell,1986.451-460.doi:10.1016/0092-8674(86)90602-1.
-
5Newbold J,Xin H,Teneza M,Sherman G,Dean J,Bowden S. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes[J].Journal of Virology,1995.3350-3357.
-
6Wu T-T,Coates L,Aldrich CE,Summers J,Mason WS. In hepatoeytes infected with duck hepatitis B virus,the template for viral RNA synthesis is amplified by an intracellular pathway[J].Virology,1990.255-261.doi:10.1016/0042-6822(90)90206-7.
-
7Moraleda G,SaputeUi J,Aldrich CE,Averett D,Condreay L,Mason WS. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus[J].Journal of Virology,1997.9392-9399.
-
8Mason WS,Cullen J,Moraleda G,Saputelli J,Aldrich CE,Miller DS. Lamivudine therapy of WHV-infected woodchucks[J].Virology,1998.18-32.doi:10.1006/viro.1998.9150.
-
9Fourel I,Cullen JM,Saputelli J,Aldrich CE,Schaffer P,Avcrett DR,etal. Evidence that hepatocyte turnover is required for rapid clearance of Duck Hepatitis B Virus during antiviral therapy of chronically infected ducks[J].Journal of Virology,1994.8321-8330.
-
10Guo JT,Zhou H,Liu C,Aldrich C,Saputelli J,Whitaker T,etal. Apoptosis and regeneration of hepatocytes during recovery from Transient the padnavirus infections[InProcessCitation][J].JViro1,2000.1495-1505.
-
1闫涛,季伟,王慧芬,张爱民,李梵.乙型肝炎病毒感染后机体免疫反应的研究进展[J].国外医学（流行病学．传染病学分册）,2004,31(4):219-222. 被引量：14
-
2许瑞艳,东野光.白细胞介素-18和1型糖尿病[J].国际内分泌代谢杂志,2006,26(3):170-172. 被引量：4
-
3张晓红,马会慧,崇雨田,肖杰生,姚集鲁.慢性乙肝患者停用拉米夫定后出现肝功能衰竭的危险因素[J].中山大学学报（医学科学版）,2005,26(3):329-332. 被引量：6
-
4孙志国.拉米夫定停药反跳致重型肝炎2例分析[J].医学信息（西安上半月）,2005,18(12):1749-1749. 被引量：1
-
5沈兰英.1例慢性乙肝使用阿德福韦酯停药反跳的护理观察[J].当代护士（上旬刊）,2013,20(12):37-38. 被引量：1
-
6高健,郑纪山,何长伦.HBV特异CTL非溶细胞性机制清除肝细胞中HBV的研究进展[J].传染病信息,2007,20(6):359-361. 被引量：2
-
7陈慧,朱启镕,王建设.非溶细胞性的抗病毒作用[J].肝脏,2002,7(3):191-192.
-
8聂聆.老年糖尿病患者的健康教育及出院指导[J].蛇志,2002,14(2):69-70.
-
9陈永杰,邹波.谁是终结者——几个月作出疫苗不可能[J].图形科普,2003(5):10-10.
-
10张小帆,刘钦,廖广群.可乐必妥治疗病毒性肝炎合并细菌感染疗效观察[J].海南医学,2003,14(10):56-57.
